Alamar Biosciences, Inc. (ALMR)
NASDAQ: ALMR · Real-Time Price · USD
32.70
-1.54 (-4.50%)
At close: Aug 24, 2026, 4:00 PM EDT
33.34
+0.64 (1.96%)
After-hours: Aug 24, 2026, 6:46 PM EDT
Alamar Biosciences Earnings Call Transcripts
Fiscal Year 2026
-
Q2 2026 revenue grew 82% year-over-year to $29.4 million, driven by strong consumables demand and platform adoption, with gross margin reaching 60%. Full-year revenue is projected at $116–$120 million, and the company remains well-capitalized post-IPO to support growth and R&D expansion.
-
A precision proteomics platform launched in 2024 has achieved rapid adoption, especially in neurology and Alzheimer's research, with strong revenue growth and industry-leading sales efficiency. Strategic priorities include expanding content, commercial reach, and moving toward clinical diagnostics, with FDA submission expected next year.